Mucinoses: Clinical Trials

1 trial for Mucinoses, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Suspended 1
Phase 21Suspended 1

Follow Mucinoses: new trials by email Literature Review of Mucinoses trials Research Report on Mucinoses

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RGX-111 Gene Therapy in Patients With MPS I
RGX-111 - Mucopolysaccharidosis Type I (MPS I), Hurler Syndrome
Phase 1 / Phase 2SuspendedREGENXBIO Inc.212019-04-032026-03-12

Narrower conditions

Mucopolysaccharidosis I (1)

Broader conditions

Carbohydrate Metabolism, Inborn Errors (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Connective Tissue Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Lysosomal Storage Diseases (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Mucopolysaccharidoses (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Sponsors

REGENXBIO Inc. (1)

Countries

Brazil (1)  ·  United States (1)

Results publications

PMID 37624739